Steve N. Slilaty

2021

In 2021, Steve N. Slilaty earned a total compensation of $462.4K as Chief Executive Officer and Director at Sunshine Biopharma.

Compensation breakdown

Salary$156,380
Stock Awards$306,000
Total$462,380

Slilaty received $306K in stock awards, accounting for 66% of the total pay in 2021.

Slilaty also received $156.4K in salary.

Rankings

In 2021, Steve N. Slilaty's compensation ranked 10,884th out of 12,415 executives tracked by ExecPay. In other words, Slilaty earned more than 12.3% of executives.

ClassificationRankingPercentile
All
10,884
out of 12,415
12th
Division
Manufacturing
4,795
out of 5,505
13th
Major group
Chemicals And Allied Products
2,149
out of 2,375
10th
Industry group
Drugs
1,911
out of 2,096
9th
Industry
Pharmaceutical Preparations
1,415
out of 1,546
9th
Source: SEC filing on October 18, 2023.

Slilaty's colleagues

We found two more compensation records of executives who worked with Steve N. Slilaty at Sunshine Biopharma in 2021.

2021

Abderrazzak Merzouki

Sunshine Biopharma

Chief Operating Officer

2021

Camille Sebaaly

Sunshine Biopharma

Chief Financial Officer

News

You may also like